Moonlighting guide ASTHMA Drugs Used in Asthma Subclass Mechanism of Action E ?ects Clinical Applications Pharmacokinetics Toxicities Beta agonists Albuterol Selective ? agonist Salbutamol Prompt e ?cacious bronchodilation Asthma chronic obstructive pulmo

ASTHMA Drugs Used in Asthma Subclass Mechanism of Action E ?ects Clinical Applications Pharmacokinetics Toxicities Beta agonists Albuterol Selective ? agonist Salbutamol Prompt e ?cacious bronchodilation Asthma chronic obstructive pulmonary disease COPD drug of choice in acute asthmatic bronchospasm Aerosol inhalation duration several hours also available for nebulizer and parenteral use Toxicity Tremor tachycardia overdose arrhythmias Salmeterol Selective ? agonist Slow onset primarily preventive action potentiates corticosteroid e ?ects Asthma prophylaxis Aerosol inhalation duration ?? h Toxicity Tremor tachycardia overdose arrhythmias Metaproterenol terbutaline Similar to albuterol terbutaline available as an oral drug Formoterol Similar to salmeterol Epinephrine Nonselective and agonist Bronchodilation plus all other sympathomimetic e ?ects on cardiovascular and other organ systems see Chapter Anaphylaxis asthma Aerosol nebulizer or parenteral others see Chapter see Chapter rarely used for asthma -selective agents preferred Isoproterenol and agonist Bronchodilation plus powerful cardiovascular e ?ects Asthma but -selective Aerosol nebulizer or parenteral agents preferred see Chapter Corticosteroids inhaled Fluticasone Alters gene expression Reduces mediators of in ammation powerful prophylaxis of exacerbations Asthma adjunct in COPD Beclomethasone budesonide unisolide others Similar to uticasone Corticosteroids systemic Prednisone Like uticasone Like uticasone Asthma adjunct in COPD Methylprednisolone Parenteral agent like prednisone Stabilizers of mast and other cells Cromolyn nedocromil Alters function of delayed Prevents acute chloride channels bronchospasm inhibits in ammatory cell activation Asthma other routes used for ocular nasal and gastrointestinal allergy Methylxanthines Theophylline Uncertain phosphodiesterase inhibition adenosine receptor antagonist Bronchodilation cardiac stimulation increased skeletal muscle strength diaphragm Asthma COPD Aerosol duration hours Toxicity Limited by aerosol application candidal infection vocal cord changes Oral duration ?? hours Toxicity Multiple see Chapter Aerosol duration ?? h Toxicity Cough not absorbed so other toxicities are minimal Oral duration ?? h but extended-release preparations often used Toxicity Multiple see text CSubclass Mechanism of Action E ?ects Leukotriene antagonists Montelukast Block leukotriene D za ?rlukast receptors Block airway response to exercise and antigen challenge Zileuton Inhibits lipoxygenase reduces synthesis of leukotrienes IgE antibody Omalizumab Humanized IgE antibody Reduces frequency of reduces circulating IgE asthma exacerbations Clinical Applications Pharmacokinetics Toxicities Prophylaxis of asthma especially in children and in aspirin-induced asthma Oral duration hours Toxicity Minimal Severe asthma Parenteral duration ?? d inadequately controlled Toxicity Injection site reactions by above agents CHRONIC ASTHMA Daytime symptom monthly Nocturnal awakening Rescue B use PEF or FEV Intermittent Weekly Less Than Mo Less Than Weekly Of Predicted GOALS Minimal or no sx Minimal attacks episodes or attack No emergency visits Minimal need for reliever No limits on physical activities and exercise Nearly normal lung fxn Minimal or no side e ?ects from meds Persistent Daily Monthly To Weekly To Nightly Wkly To Daily Several Times A Day - Of Predicted ANTIMICROBIAL FOR UTI AND PNEUMONIA CEPHALOSPHORINS Guidelines for Dosing of Some Commonly Used Cephalosporins and Other Cell-Wall Inhibitor Antibiotics Antibiotic Route of Adult Dose Pediatric Dose Administration Neonatal Dose Adjusted Dose as a Percentage of Normal Dose for Renal Failure Based on Creatinine Clearance Clcr First-generation cephalosporins Cefadroxil PO ?? g qd ??bid mg

Documents similaires
La chasse et le droit constitutionnel louis favoreu rfda 2000 664 2 0 0
Etude d x27 outillage REPUBLIQUE DU CAMEROUN Paix-Travail-Patrie ------------- MINESEC OBC Baccalauréat F Session ? ? ? ? ? Série F Fabrication Mécanique Durée heures min Coe ?cient Epreuve écrite ETUDE D ? OUTILLAGE DDOOSSSSIEIERRSSUUJJEETT DDOOCCUUMMENE 0 0
Fiche de dotation FICHE DE DOTATION EQUIPEMENTS DE PROTECTION INDIVIDUELLE Service Prévention et Sécurité au Travail Fiche Santé et Travail n Date VF SERVICE NOM DATE Désignation de l ? équipement METIER PRENOM Taille Fréquence de renouvellement sous rése 0 0
J3800 DOSSIER Techniques de l ? Ingénieur l ? expertise technique et scienti ?que de référence j Agitation Mélange - Concepts théoriques de base Par Michel ROUSTAN Ingénieur INSA Institut national des sciences appliquées de Toulouse Professeur de génie ch 0 0
Avec l’approbation de et le soutien de ESTIMATION DE L’INCERTITUDE DE MESURE AP 0 0
Repartition 1am 22 23 République Algérienne Démocratique et Populaire Ministère de l ? Education nationale Direction de l ? Education de Bechar Année scolaire Inspection de l ? Enseignement Moyen ??L fr Circonscriptions MOSTAGANEM Niveau è AM Plan annuel 0 0
Avis de situation 3 Page C ID KCX Références à rappeler numéro identi ?ant R M IMPERATO THIERRY RUE SAINT BAUDILLE LIEURAN CABRIERES NANTERRE le er novembre KCX Objet Attestation Monsieur IMPERATO Pôle emploi certi ?e que vous avez été admis au béné ?ce d 0 0
Blabla 1 Examen Bocal bocal fr Résumé Ce document est votre sujet d ? examen CTable des matières I Détails administratifs I Consignes générales I Le Code I Types d ? exercices II Exercices II Exercice - max II Exercice - str capitalizer II Exercice - ft s 0 0
Module 02 technologie d x27 entretien tsti thermique industrielle 0 0
Acces aux brevets en langage naturel 1 0 0
  • 103
  • 0
  • 0
Afficher les détails des licences
Licence et utilisation
Gratuit pour un usage personnel Attribution requise
Partager
  • Détails
  • Publié le Oct 28, 2022
  • Catégorie Administration
  • Langue French
  • Taille du fichier 90.5kB